We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRSVW
551
DELISTED
Gores Holdings V, Inc. Warrant
GRSVW
$792K 0.01%
399,787
-50,196
-11% -$89.1K
ADT icon
552
ADT
ADT
$5.58B
$777K 0.01%
71,985
RKLBW
553
DELISTED
Rocket Lab USA, Inc. Warrant
RKLBW
$765K 0.01%
266,656
XOSWW
554
Xos Inc Warrants
XOSWW
$12.2K
$747K 0.01%
401,566
DOMA
555
DELISTED
Doma Holdings, Inc.
DOMA
$737K 0.01%
2,956
-11,043
-79% -$2.74M
VYGG.WS
556
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$728K 0.01%
399,985
RBOT
557
DELISTED
Vicarious Surgical
RBOT
$723K 0.01%
2,417
-14,249
-85% -$4.24M
DFNS.WS
558
DELISTED
LGL Systems Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for shares of Clas
DFNS.WS
$716K 0.01%
393,234
-351,370
-47% -$518K
CFLT
559
DELISTED
Confluent
CFLT
$712K 0.01%
+15,000
New +$725K
SHACW
560
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$702K 0.01%
866,222
CONXW
561
DELISTED
CONX Corp. Warrant
CONXW
$680K 0.01%
499,982
NSH.WS
562
DELISTED
NavSight Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Sto
NSH.WS
$671K 0.01%
398,092
-100,391
-20% -$139K
PDAC.WS
563
DELISTED
Peridot Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordina
PDAC.WS
$671K 0.01%
250,979
SPRQ.WS
564
DELISTED
Spartan Acquisition Corp. II Warrants, exercisable for one share of Class A Common Stock
SPRQ.WS
$667K 0.01%
374,987
TOIIW
565
DELISTED
The Oncology Institute Warrant
TOIIW
$655K 0.01%
372,284
CCAC.WS
566
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
$641K 0.01%
602,262
FGNA.WS
567
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$610K 0.01%
274,990
GNPK.WS
568
DELISTED
Genesis Park Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A o
GNPK.WS
$609K 0.01%
249,991
HZAC.WS
569
DELISTED
Horizon Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary sh
HZAC.WS
$603K 0.01%
333,321
+218
+0.1% +$337
ET icon
570
CALL
Energy Transfer Partners
ET
$69.3B
$595K 0.01%
+1,400,000
New +$13.4M
IIAC.WS
571
DELISTED
Investindustrial Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class
IIAC.WS
$595K 0.01%
566,645
NOACW
572
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$594K 0.01%
824,970
F icon
573
CALL
Ford
F
$55.7B
$586K 0.01%
1,150,000
-100,000
-8% -$1.33M
DOCS icon
574
Doximity
DOCS
$5B
$582K 0.01%
+10,000
New +$561K
TWCTW
575
DELISTED
TWC Tech Holdings II Corp. Warrant
TWCTW
$578K 0.01%
333,321
+218
+0.1% +$329

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.